Northwire Canada EditionSaturday, October 17, 2026
Northwire
⌕
GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% GOLD 4181.10 +0.3% SILVER 57.30 +0.3% COPPER 6.57 +0.3% OIL 99.02 +1.1% PALLADIUM 1118.60 −0.9% GBU 0.095 +0.0% ATY 0.225 +4.7% GRDM 0.215 +0.0% PPM 0.300 +0.0% GZD 0.040 −11.1% CAN 0.060 +0.0% BGF 0.025 +0.0% MSV 0.570 +0.0% CCMM 0.485 +0.0% MON 0.385 −6.1% OMI 0.245 −2.0% BUFF 0.800 +2.6% FEO 0.630 −3.1% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0%

Healthcare

Page 66
  1. Feb 03, 2026 · 08:50 · OTC

    Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology

    Ocumetics Reports Positive Three Month First-in-Human Results, Significantly De-Risking Its Accommodating Intraocular Lens Technology

    01
  2. Feb 03, 2026 · 07:00 · LOBE

    Lobe Sciences Reports First Quarter 2026 Results and Highlights

    Lobe Sciences Reports First Quarter 2026 Results and Highlights

    02
  3. Feb 02, 2026 · 21:05 · MDX

    MedX Health arranges $5-million note financing

    MedX Health arranges $5-million note financing

    03
  4. Feb 02, 2026 · 19:08 · PHRM

    Pharmather seeks to commercialize generic semaglutide

    Pharmather seeks to commercialize generic semaglutide

    04
  5. Feb 02, 2026 · 18:21 · SEGN

    Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

    Seegnal Expands Deployment of Seegnal's Prescription Intelligence Platform at Tel Aviv Sourasky Medical Center, a Leading Israeli Public Medical Center and Global Referral Center

    05
  6. Feb 02, 2026 · 17:46 · MBIO

    Mindbio pitches AI voice drug tests to miners

    Mindbio pitches AI voice drug tests to miners

    06
  7. Feb 02, 2026 · 17:38 · NURS

    Hydreight estimates 2026 revenue of $150-million

    Hydreight estimates 2026 revenue of $150-million

    07
  8. Feb 02, 2026 · 17:01 · MDX

    MedX Announces Non-Brokered Private Placement of Series IV Convertible Loan Notes

    MedX Announces Non-Brokered Private Placement of Series IV Convertible Loan Notes

    08
  9. Feb 02, 2026 · 16:25 · TLT

    Theralase treats 90 patients in bladder cancer study

    Theralase treats 90 patients in bladder cancer study

    09
  10. Feb 02, 2026 · 14:22 · NLH

    Nova Leap sets up palliative care division in N.S.

    Nova Leap sets up palliative care division in N.S.

    10
  11. Feb 02, 2026 · 12:41 · VIVI

    Tempramed forms media partnership with Dr. Phil, Envoy

    Tempramed forms media partnership with Dr. Phil, Envoy

    11
  12. Feb 02, 2026 · 12:20 · DR

    Medical Facilities completes sale of interest in OSH

    Medical Facilities completes sale of interest in OSH

    12
  13. Feb 02, 2026 · 12:10 · SHRX

    Sharp Therapeutics Announces Private Placement of up to US$3.0 Million in Unsecured Convertible Notes

    Sharp Therapeutics Announces Private Placement of up to US$3.0 Million in Unsecured Convertible Notes

    13
  14. Feb 02, 2026 · 09:28 · PHRM

    PharmaTher Launches Strategic Initiative to Pursue Health Canada Approval for Generic Semaglutide in Canada, Building on FDA-Approved Ketamine Success

    PharmaTher Launches Strategic Initiative to Pursue Health Canada Approval for Generic Semaglutide in Canada, Building on FDA-Approved Ketamine Success

    14
← Newer Older →